Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. (Q43075467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

1 February 2020

main subject

0 references

author

Mary E. Abood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gregory Carter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Sunil K Aggarwal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michael D Weiss

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

3 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Hospice and Palliative Medicine

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

347-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20439484%20AND%20SRC:MED&resulttype=core&format=json

The natural history of ALS is changing: improved survival

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

ALS: a disease of motor neurons and their nonneuronal neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Recent advances in motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Neurotrophic factors in neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The endocannabinoid system in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Marijuana in the management of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Long-term safety of riluzole in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Survey of cannabis use in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoids and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Significance of cannabinoid CB1 receptors in improgan antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

An Aromatic Microdomain at the Cannabinoid CB1 Receptor Constitutes an Agonist/Inverse Agonist Binding Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Control of the cell survival/death decision by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The cannabinoid system and cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Endocannabinoids: new targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoid receptor antagonism increases female sexual motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoids as novel anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Neurobiology and systems physiology of the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

An introduction to the endocannabinoid system: from the early to the latest concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Anandamide receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Endocannabinoids and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Endocannabinoids in the immune system and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Neuroprotective agents for clinical trials in ALS: a systematic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Examining the roles of cannabinoids in pain and other therapeutic indications: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

In-vitro and in-vivo action of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Preface: the state of the science of all motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The therapeutic potential of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoids and brain injury: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The amyotrophic lateral sclerosis center: a model of multidisciplinary management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Expanding the role of hospice care in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Quality of life in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

An analgesia circuit activated by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Systematic review and meta-analysis of cannabis treatment for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Nutrition and dietary supplements in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Vaporization as a smokeless cannabis delivery system: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabis smoke condensate III: the cannabinoid content of vaporised Cannabis sativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Medical marijuana: emerging applications for the management of neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Emerging roles for endocannabinoids in long‐term synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

History of cannabis and its preparations in saga, science, and sobriquet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531

Recent advances in the genetics of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909110369531